Which NSAID may be used in asthma management?

The correct choice involves understanding the role of specific nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with asthma and their potential effects. While aspirin is commonly associated with exacerbating asthma symptoms in certain individuals due to its ability to induce bronchospasm and increase bronchial hyperreactivity, meclofenamate has shown some potential benefits for those with asthma.

Meclofenamate is less likely to provoke hypersensitivity reactions in asthmatic patients compared to other NSAIDs, making it more suitable for managing pain or inflammation without worsening respiratory conditions. This unique aspect distinguishes it from the other options, which may lead to adverse asthma symptoms in susceptible individuals.

In contrast, diclofenac and oxaprozin do not carry specific benefits or lower risks for asthma management and may also contribute to potential asthma flares. Hence, meclofenamate stands out as the more appropriate choice in this context.